SALSA MLPA Probemix P050 CAH has been updated and CE-marked
May 23, 2022
We are glad to announce the release of a new and improved version of our SALSA® MLPA® Probemix P050 CAH for congenital adrenal hyperplasia, which now has also been CE-marked.
New version improvements (P050-D1):
- Major design update, incl. redesign of the I2G targeting probes.
- Validated for use with DNA isolated from prenatal samples.
- Updated Instructions for Use (IFU): clearer instructions for result interpretation and the selection of suitable reference samples; examples on interpretation of complex cases included.
With this new and improved CE-marked P050 CAH assay, customers will obtain better quality results, with simpler data analysis and interpretation.